Cite
Concurrent chemoradiotherapy followed by metastasectomy converts to survival benefit in stage IV rectum cancer.
MLA
Lin JK, et al. “Concurrent Chemoradiotherapy Followed by Metastasectomy Converts to Survival Benefit in Stage IV Rectum Cancer.” Journal of Gastrointestinal Surgery, vol. 16, no. 10, Oct. 2012, pp. 1888–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=104295761&authtype=sso&custid=ns315887.
APA
Lin JK, Lee LK, Chen WS, Lin TC, Jiang JK, Yang SH, Wang HS, Chang SC, Lan YT, Lin CC, Yen CC, Liu JH, Tzeng CH, Teng HW, Lin, J.-K., Lee, L.-K., Chen, W.-S., Lin, T.-C., Jiang, J.-K., & Yang, S.-H. (2012). Concurrent chemoradiotherapy followed by metastasectomy converts to survival benefit in stage IV rectum cancer. Journal of Gastrointestinal Surgery, 16(10), 1888–1896.
Chicago
Lin JK, Lee LK, Chen WS, Lin TC, Jiang JK, Yang SH, Wang HS, et al. 2012. “Concurrent Chemoradiotherapy Followed by Metastasectomy Converts to Survival Benefit in Stage IV Rectum Cancer.” Journal of Gastrointestinal Surgery 16 (10): 1888–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=104295761&authtype=sso&custid=ns315887.